Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1973 Mar;47(3):487–497. doi: 10.1111/j.1476-5381.1973.tb08180.x

The effect of β-adrenoceptor blockade on human sweating

Judith A Allen, D J Jenkinson, I C Roddie
PMCID: PMC1776319  PMID: 4147190

Abstract

1. Changes in cutaneous water loss were followed by continuously monitoring total body weight loss.

2. Sweating was induced in normal subjects by raising the environmental temperature or by subjecting them to the emotional stress of mental arithmetic.

3. Propranolol in a dosage of 0·15 mg/kg body weight intravenously had no significant effect on either thermal or emotional sweating, whereas thermal sweating was completely blocked temporarily by administration of atropine 2·4 mg intravenously.

4. It is concluded that β-adrenoceptor blockade has no effect on physiological sweating in normal people.

Full text

PDF
487

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. A., Grimley J. F., Roddie I. C. A body balance to measure sweat rates in man. Biomed Eng. 1971 Oct;6(10):468–471. [PubMed] [Google Scholar]
  2. Allen J. A., Roddie I. C. The role of circulating catecholamines in sweat production in man. J Physiol. 1972 Dec;227(3):801–814. doi: 10.1113/jphysiol.1972.sp010059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brick I., Hutchinson K. J., Roddie I. C. Beta adrenergic blocking properties of D and DL propränolol in man. Ir J Med Sci. 1970 Mar;3(3):123–130. doi: 10.1007/BF02955227. [DOI] [PubMed] [Google Scholar]
  4. CHALMERS T. M., KEELE C. A. The nervous and chemical control of sweating. Br J Dermatol. 1952 Feb;64(2):43–54. doi: 10.1111/j.1365-2133.1952.tb16160.x. [DOI] [PubMed] [Google Scholar]
  5. Cummings E. G., Craig F. N. Influence of the rate of sweating on the inhibitory dose of atropine. J Appl Physiol. 1967 Apr;22(4):648–654. doi: 10.1152/jappl.1967.22.4.648. [DOI] [PubMed] [Google Scholar]
  6. Foster K. G., Weiner J. S. Effects of cholinergic and adrenergic blocking agents on the activity of the eccrine sweat glands. J Physiol. 1970 Nov;210(4):883–895. doi: 10.1113/jphysiol.1970.sp009247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hedges A., Turner P. Effect of five beta-adrenoceptor antagonists on the effect of isoprenaline and acetylcholine on human isolated smooth muscle. Br J Pharmacol. 1971 Feb;41(2):426P–427P. [PMC free article] [PubMed] [Google Scholar]
  8. JAMES T. N., NADEAU R. A. Chronotropic and vagal-blocking effects of DCI studied by direct perfusion of the sinus node. J Pharmacol Exp Ther. 1963 Apr;140:73–78. [PubMed] [Google Scholar]
  9. JAMES T. N., NADEAU R. A. THE CHRONOTROPIC AND VAGAL-BLOCKING ACTIONS OF NAPHTHYLISOPROTERENOL STUDIED BY DIRECT PERFUSION OF THE SINUS NODE. J Pharmacol Exp Ther. 1964 Mar;143:350–355. [PubMed] [Google Scholar]
  10. MORALES AGUILERA A., VAUGHANWILLIAMS E. M. THE EFFECTS ON CARDIAC MUSCLE OF BETA-RECEPTOR ANTAGONISTS IN RELATION TO THEIR ACTIVITY AS LOCAL ANAESTHETICS. Br J Pharmacol Chemother. 1965 Apr;24:332–338. doi: 10.1111/j.1476-5381.1965.tb01719.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Shanks R. G., Hadden D. R., Lowe D. C., McDevitt D. G., Montgomery D. A. Controlled trial of propranolol in thyrotoxicosis. Lancet. 1969 May 17;1(7603):993–994. doi: 10.1016/s0140-6736(69)91797-8. [DOI] [PubMed] [Google Scholar]
  12. WEBB P., GARLINGTON L. N., SCHWARZ M. J. Insensible weight loss at high skin temperatures. J Appl Physiol. 1957 Jul;11(1):41–44. doi: 10.1152/jappl.1957.11.1.41. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES